Citation

Liu C, Lin J, Wrobleski ST, Lin S, Hynes J, Wu H, Dyckman AJ, Li T, Wityak J, Gillooly KM, Pitt S, Shen DR, Zhang RF, McIntyre KW, Salter-Cid L, Shuster DJ, Zhang H, Marathe PH, Doweyko AM, Sack JS, Kiefer SE, Kish KF, Newitt JA, McKinnon M, Dodd JH, Barrish JC, Schieven GL, Leftheris K.: Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. J Med Chem, Volume 53 (18), 2010

Authors

Barrish JC, Dodd JH, Doweyko AM, Dyckman AJ, Gillooly KM, Hynes J, Kiefer SE, Kish KF, Leftheris K., Li T, Lin J, Lin S, Liu C, Marathe PH, McIntyre KW, McKinnon M, Newitt JA, Pitt S, Sack JS, Salter-Cid L, Schieven GL, Shen DR, Shuster DJ, Wityak J, Wrobleski ST, Wu H, Zhang H, Zhang RF

Journal

J Med Chem

Year

2010

DOI

10.1021/jm100540x

PubMed

20804198

Machine-readable

REST APIRDF